about
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary ...
Read More
4.99
0.04
(0.81%)
1.2M
XNAS Volume
XNAS 17 Jul, 2026 12:31 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Precigen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..